Source: Annual Congress 2010 - New toys, old problems: extrapleural lung volume reduction, sedation and comfort in bronchoscopy



Rating:

Share or cite this content

Citations should be made in the following way:
L. Schlatter, M. Tamm, A. Meyer, B. Fehrke, M. Ortmann, E. Pflimlin, W. Strobel, D. Stolz (Switzerland). Propofol versus the combination propofol/hydrocodone sedation in flexible bronchoscopy – A randomized, placebo-controlled, double-blind study. Eur Respir J 2010; 36: Suppl. 54, 4130

Member's Comments

No comment yet.

Related content which might interest you: Propofol versus combined sedation in flexible bronchoscopy – a randomised, non-inferiority trial Source: Annual Congress 2009 - Stents, needles and sedation Year: 2009 Propofol sedation for flexible bronchoscopy: A large randomized, controlled, non-inferiority trial Source: Annual Congress 2012 - The broad spectrum of diagnostic bronchoscopy Year: 2012 Propofol sedation for flexible bronchoscopy: a randomised, noninferiority trial Source: Eur Respir J 2014; 43: 591-601 Year: 2013 A multicenter, randomized, double-blind, double-dummy, 2-way crossover, single dose study, comparing the efficacy and safety of the fluticasone/salmeterol (500/50 μg) combination administered with the new Elpenhaler inhalation device versus the innovative one in patients with asthma Source: Annual Congress 2009 - Quality of treatment in primary respiratory care Year: 2009 The efficacy and safety of topical phenylephrine before flexible bronchoscopy: a double-blind, randomized controlled trial Source: Annual Congress 2008 - News from diagnostic bronchoscopy Year: 2008 Sedation for bronchoscopy in children: a prospective randomized double-blinded trial Source: Virtual Congress 2021 – Posters in paediatric bronchology Year: 2021 Propofol versus combined sedation in flexible bronchoscopy: a randomised non-inferiority trial Source: Eur Respir J 2009; 34: 1024-1030 Year: 2009 Impact of oral clonidine on duration of opioid and benzodiazepine use in mechanically ventilated children: a randomized, double-blind, placebo-controlled study Source: Virtual Congress 2020 – Neonatal and paediatric intensive care: diagnosis, management and outcomes Year: 2020 Randomised, double-blind, placebo-controlled trial of EPS® 7630 in adults with COPD Source: Annual Congress 2009 - Healthcare and treatment of COPD Year: 2009 Utility of anticholinergic premedication for bronchoscopy: a randomized controlled trial Source: Eur Respir J 2005; 26: Suppl. 49, 531s Year: 2005 Acetazolamide administration following upper airway surgery for SDB. Preliminary results of a randomized, double-blind, placebo-controlled study Source: Eur Respir J 2005; 26: Suppl. 49, 201s Year: 2005 Tiotropium treatment for bronchiectasis (ROBUST): a randomized, placebo-controlled, crossover trial Source: International Congress 2017 – Bronchodilators and bronchoprotectors Year: 2017 Efficacy and safety of revefenacin (REV), a long-acting muscarinic antagonist for nebulization: results of replicate randomized, double-blind, placebo-controlled, parallel-group phase 3 trials in participants with moderate to very severe COPD Source: International Congress 2017 – Bronchodilators and bronchoprotectors Year: 2017 Glycopyrronium does not affect QT interval in healthy subjects: A randomized, 3-period cross-over, placebo- and positive-controlled study Source: Annual Congress 2013 –LAMA, LABA, ICS and their combinations for the treatment of asthma and COPD Year: 2013 The use of modafinil in patients with obstructive apnoea-hyponoea syndrome (OAHS). A randomized, placebo-controlled, double-blind study Source: Eur Respir J 2001; 18: Suppl. 33, 419s Year: 2001 PRAISE, a randomized, placebo-controlled, double-blind Phase 2 clinical trial of pamrevlumab (FG-3019) in IPF patients Source: International Congress 2017 – Idiopathic pulmonary fibrosis (IPF): treatment highlights Year: 2017 Methotrexate in treatment of severe difficult-to-treat asthma: randomized, double-blind, placebo-controlled study Source: Annual Congress 2007 - Towards controlling severe asthma Year: 2007 Glycopyrrolate MDI demonstrates comparable efficacy and safety to tiotropium DPI in a randomized, double-blind, placebo-controlled phase 2b study in patients with COPD Source: Annual Congress 2011 - Drug delivery and pharmacokinetics II Year: 2011 Randomized, double-blind, controlled trial of preventive inhalation of hypertonic saline in infants with CF (PRESIS) Source: International Congress 2018 – Cystic fibrosis: microbiological aspects and new treatments Year: 2018 The effect of bronchodilators in the exercise capacity and thoracoabdominal mechanics of subjects with bronchiectasis: a randomized crossover, double-blinded, placebo-controlled trial Source: Virtual Congress 2020 – Exercise tolerance and functional status across respiratory diseases Year: 2020